Implementation of Suicide Care in Primary Care Cuts Rate of Suicide Attempts
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 30, 2024 -- Implementation of population-based suicide care (SC) in primary care yields an increase in the rates of safety planning and a reduction in suicide attempts, according to a study published online Oct. 1 in the Annals of Internal Medicine.
Julie Angerhofer Richards, Ph.D., M.P.H., from the Kaiser Permanente Washington Heath Research Institute in Seattle, and colleagues examined the effectiveness of implementing population-based SC in primary care in a secondary analysis of a stepped-wedge, cluster randomized implementation trial. The study compared usual care (UC) and SC periods for adult patients with primary care visits from January 2015 to July 2018. Implementation of depression screening, suicide risk assessment, and safety planning was supported by practice facilitators, electronic medical record clinical decision support, and performance monitoring in the intervention.
Overall, 255,789 patients made 953,402 primary care visits during UC and 228,255 patients made 615,511 visits during SC. The researchers found that the rates of safety planning increased from 39.6 to 46.2 per 10,000 patients comparing UC with SC; in addition, there was a decrease in suicide attempts within 90 days, from 6.57 to 4.93 per 10,000 patients.
"Strategies to improve suicide risk identification and mitigation in primary care implemented alongside a substance care program are effective in reducing suicide attempts," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-01 12:00
Read more
- Fasting at Night May Aid Glucose Metabolism in Night-Shift Workers
- 80.5 Percent of Teens Experience at Least One Adverse Childhood Experience
- Transcranial Direct Current Stimulation Safe, Effective for Tardive Dyskinesia
- One Day of the Week Has Highest Suicide Risk
- U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for Adults Aged 18 to 59 at Increased Risk for Disease
- Over 40? Get Fitter and Live 5 Extra Years
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions